Prestige Brands to buy Insight Pharma for $750 million

Prestige Brands is buying the company behind the Monistat brand of yeast-infection treatments
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.